| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |